Furthermore, junction J3 was a specific feature of the transcriptomes of primary AML subtypes with a more mature immunophenotype than t(8;21) AML, but of neither t(8;21)-positive AMLs nor normal CD34-positive haematopoietic stem and progenitor cells (Supplementary Fig. 3e). The gene discussed is CD34; the disease is acute myeloid leukemia.